Page last updated: 2024-11-06
chloromethylstyrene
Description
Chloromethylstyrene (CMS) is an organic compound that exists as a colorless liquid. It is a reactive compound that is primarily used as a monomer in the synthesis of various polymers and resins, particularly in the production of ion exchange resins. CMS is synthesized through a Friedel-Crafts alkylation reaction of styrene with chloromethyl methyl ether (CMME) in the presence of a Lewis acid catalyst like zinc chloride. The compound is known to be a potential irritant to skin and eyes, and inhalation may cause respiratory irritation. Research on chloromethylstyrene is driven by its significance in the chemical industry, particularly in the production of ion exchange resins which are widely employed in various applications like water treatment, pharmaceutical production, and metal separation. The reactivity and versatility of CMS in polymer synthesis make it a subject of ongoing research to develop new materials with improved properties. However, concerns regarding its toxicity and environmental impact necessitate further exploration of safer alternatives for its synthesis and use. '
chloromethylstyrene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 94242 |
MeSH ID | M0545836 |
Synonyms (17)
Synonym |
benzene, (3-chloro-1-propenyl)- |
ai3-01855 |
einecs 220-246-4 |
chloromethylstyrene |
3-chloroprop-1-enylbenzene |
FT-0623841 |
1-chloro-3-phenyl-2-propene |
(3-chloro-1-propenyl)benzene |
IWTYTFSSTWXZFU-UHFFFAOYSA-N |
FT-0772556 |
DTXSID6062591 |
3-phenylallyl chloride |
(3-chloro-prop-1-enyl)-benzene |
Q1092543 |
FT-0776061 |
(e)-(3-chloro-1-propen-1-yl)benzene |
SY303284 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 33.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 33.02 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.92 (4.65) | Search Engine Demand Index | 34.93 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |